OncoC4 Receives FDA Fast Track for Cesalatamig
Rockville, Maryland, USA, September 16, 2026 OncoC4, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...
sleep medicine
Advertisement
Viatris WAKIX Approved in Japan for Sleep Disorders
Tokyo, Japan, September 16, 2026 Viatris Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved...
Nyxoah Begins U.S. BREATHE Study With First Genio Implant
Mont-Saint-Guibert, Belgium — September 7, 2026 Nyxoah announced that the first patient has been implanted in BREATHE, its U.S....
HoneyNaps Expands AI Clinical Trial Analytics as CRO
BOSTON, July 27, 2026 HoneyNaps has officially registered as a Contract Research Organization (CRO) with the Korea National Enterprise...
Apnimed Targets First Oral Sleep Apnea Therapy with FDA NDA
CAMBRIDGE, Mass., July 14, 2026 Apnimed, Inc. has achieved a significant regulatory milestone after the U.S. Food and Drug...
Advertisements
Apnimed Appoints Industry Veterans to Drive AD109 Growth
CAMBRIDGE, Mass., July 1, 2026 Apnimed has strengthened its executive leadership team with the appointments of Michael Kelly as...
Jazz Presents New Xywav Data at SLEEP 2026 Meeting
DUBLIN, Ireland, June 16, 2026 Jazz Pharmaceuticals plc has unveiled extensive late-breaking research at SLEEP 2026, presenting 11 new...
Takeda Oveporexton Shows Broad Benefits in Narcolepsy
OSAKA, Japan and CAMBRIDGE, Massachusetts, June 15, 2026 Takeda has unveiled new pivotal Phase 3 data demonstrating that oveporexton...
Teva Acquires Emalex to Advance Tourette Syndrome Therapy
TEL AVIV, Israel, June 10, 2026 Teva Pharmaceutical Industries Ltd. has completed its acquisition of Emalex Biosciences, strengthening its...
Eli Lilly and Shaquille O’Neal Raise Awareness of Treatable Sleep Apnea with Zepbound
INDIANAPOLIS, United States, June 10, 2026 Eli Lilly and Company has launched a nationwide awareness campaign featuring NBA legend...
Advertisement
